Free Trial

60 Degrees Pharmaceuticals (SXTP) Competitors

60 Degrees Pharmaceuticals logo
$2.26 -0.09 (-3.83%)
Closing price 04:00 PM Eastern
Extended Trading
$2.25 -0.01 (-0.44%)
As of 07:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SXTP vs. GOVX, EQ, EDSA, LPTX, MEIP, PRPH, GELS, ME, RLMD, and TRIB

Should you be buying 60 Degrees Pharmaceuticals stock or one of its competitors? The main competitors of 60 Degrees Pharmaceuticals include GeoVax Labs (GOVX), Equillium (EQ), Edesa Biotech (EDSA), Leap Therapeutics (LPTX), MEI Pharma (MEIP), ProPhase Labs (PRPH), Gelteq (GELS), 23andMe (ME), Relmada Therapeutics (RLMD), and Trinity Biotech (TRIB). These companies are all part of the "pharmaceutical products" industry.

60 Degrees Pharmaceuticals vs.

GeoVax Labs (NASDAQ:GOVX) and 60 Degrees Pharmaceuticals (NASDAQ:SXTP) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, community ranking, institutional ownership, analyst recommendations, profitability and media sentiment.

GeoVax Labs has a beta of 3.47, indicating that its stock price is 247% more volatile than the S&P 500. Comparatively, 60 Degrees Pharmaceuticals has a beta of 3.02, indicating that its stock price is 202% more volatile than the S&P 500.

In the previous week, GeoVax Labs and GeoVax Labs both had 1 articles in the media. GeoVax Labs' average media sentiment score of 0.00 beat 60 Degrees Pharmaceuticals' score of -1.50 indicating that GeoVax Labs is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
GeoVax Labs
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
60 Degrees Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Negative

60 Degrees Pharmaceuticals' return on equity of 0.00% beat GeoVax Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
GeoVax LabsN/A -809.87% -349.34%
60 Degrees Pharmaceuticals N/A N/A -113.43%

60 Degrees Pharmaceuticals has lower revenue, but higher earnings than GeoVax Labs. GeoVax Labs is trading at a lower price-to-earnings ratio than 60 Degrees Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GeoVax Labs$5.59M2.77-$25.97M-$3.65-0.28
60 Degrees Pharmaceuticals$665.45K5.08-$3.77M-$50.41-0.05

GeoVax Labs presently has a consensus target price of $11.10, indicating a potential upside of 988.24%. Given GeoVax Labs' stronger consensus rating and higher possible upside, equities analysts plainly believe GeoVax Labs is more favorable than 60 Degrees Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GeoVax Labs
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
2 Strong Buy rating(s)
3.29
60 Degrees Pharmaceuticals
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

GeoVax Labs received 29 more outperform votes than 60 Degrees Pharmaceuticals when rated by MarketBeat users. Likewise, 96.77% of users gave GeoVax Labs an outperform vote while only 4.76% of users gave 60 Degrees Pharmaceuticals an outperform vote.

CompanyUnderperformOutperform
GeoVax LabsOutperform Votes
30
96.77%
Underperform Votes
1
3.23%
60 Degrees PharmaceuticalsOutperform Votes
1
4.76%
Underperform Votes
20
95.24%

6.1% of GeoVax Labs shares are held by institutional investors. Comparatively, 8.0% of 60 Degrees Pharmaceuticals shares are held by institutional investors. 1.2% of GeoVax Labs shares are held by company insiders. Comparatively, 10.3% of 60 Degrees Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

GeoVax Labs beats 60 Degrees Pharmaceuticals on 10 of the 17 factors compared between the two stocks.

Get 60 Degrees Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SXTP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SXTP vs. The Competition

Metric60 Degrees PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$3.38M$6.51B$5.34B$8.44B
Dividend YieldN/A2.64%5.21%4.11%
P/E Ratio-0.239.2026.9019.78
Price / Sales5.08258.37389.48118.91
Price / CashN/A65.8538.2534.62
Price / Book-0.226.466.784.52
Net Income-$3.77M$144.21M$3.23B$248.23M
7 Day Performance6.74%2.66%2.02%0.81%
1 Month Performance-14.04%4.83%10.97%13.32%
1 Year Performance59.87%-2.54%17.38%7.69%

60 Degrees Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SXTP
60 Degrees Pharmaceuticals
0.6486 of 5 stars
$2.26
-3.8%
N/A+68.4%$3.33M$665,452.00-0.223Negative News
Earnings Report
GOVX
GeoVax Labs
2.7902 of 5 stars
$0.93
-0.3%
$11.10
+1,099.9%
-39.1%$14.06M$5.59M-0.2510Positive News
EQ
Equillium
2.6324 of 5 stars
$0.39
-0.1%
$3.00
+669.2%
-74.5%$13.93M$41.10M-2.7940
EDSA
Edesa Biotech
2.8447 of 5 stars
$1.98
-3.4%
$21.00
+960.6%
-55.7%$13.91MN/A-1.0620Analyst Revision
LPTX
Leap Therapeutics
2.43 of 5 stars
$0.38
+12.0%
$4.92
+1,210.8%
-85.6%$13.88MN/A-0.1940Positive News
Gap Up
MEIP
MEI Pharma
2.1973 of 5 stars
$2.08
+1.3%
N/A-31.1%$13.83M$65.30M-0.36100
PRPH
ProPhase Labs
1.8391 of 5 stars
$0.33
+7.9%
N/A-94.4%$13.69M$6.77M-0.26130News Coverage
Earnings Report
Gap Up
GELS
Gelteq
N/A$1.44
+5.1%
N/AN/A$13.59MN/A0.00N/APositive News
ME
23andMe
N/A$0.50
-35.3%
N/A-95.3%$13.36M$208.78M-0.03770Gap Down
High Trading Volume
RLMD
Relmada Therapeutics
4.431 of 5 stars
$0.40
-4.6%
$4.25
+962.5%
-84.0%$13.28MN/A-0.1410Positive News
Insider Trade
Gap Down
TRIB
Trinity Biotech
0.735 of 5 stars
$0.73
-3.1%
N/A-49.9%$13.18M$59.13M-0.32480

Related Companies and Tools


This page (NASDAQ:SXTP) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners